Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_assertion description "[Taken together, our data suggest that anti-VEGFa treatment in cervical cancer may inhibit both tumor cell growth and invasion through PI3k/Akt/mTor signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_assertion evidence source_evidence_literature NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_assertion SIO_000772 25135429 NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_assertion wasDerivedFrom befree-2016 NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_assertion wasGeneratedBy ECO_0000203 NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1211777.RAbZcj_nX7O7J13-mW0hsL6eCTemYv3nwYAn14mmO1Azo130_provenance.